Author

Rohit Thummalapalli

Memorial Sloan Kettering Cancer CenterORCID 0000-0002-8865-0299Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Anupriya SinghaliD· 1 shared Charles M. RudiniD· 1 shared Chun‐Hao PaniD· 1 shared Eusebio ManchadoiD· 1 shared James G. ChristenseniD· 1 shared Jason C. ChangiD· 1 shared Jill F. HalliniD· 1 shared Lukas E. DowiD· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Anupriya SinghalORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyCancer DiscoveryPeer-reviewedNov 6, 2023

Alveolar differentiation drives resistance to KRAS inhibition in lung adenocarcinoma

Zhuxuan Li, Xueqian Zhuang, Chun‐Hao Pan…·Tuomas Tammela

This study shows that KRAS inhibition in lung adenocarcinoma leads to an AT1-like cell state that drives resistance, and targeting these cells improves treatment response.

79 citationstop 1%

mousehuman

𝕏 PostBluesky